|
|
Volumn 31 Suppl 2, Issue , 2008, Pages
|
|
Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ANTIDIABETIC AGENT;
GLIBENCLAMIDE;
INSULIN;
METFORMIN;
SULFONYLUREA DERIVATIVE;
ARTICLE;
CARDIOVASCULAR DISEASE;
DIABETIC ANGIOPATHY;
HUMAN;
INSULIN RESISTANCE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATHOPHYSIOLOGY;
CARDIOVASCULAR DISEASES;
DIABETES MELLITUS, TYPE 2;
DIABETIC ANGIOPATHIES;
GLYBURIDE;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN;
INSULIN RESISTANCE;
METFORMIN;
SULFONYLUREA COMPOUNDS;
THIAZOLIDINEDIONES;
MLCS;
MLOWN;
|
|
EID: 41149109526
PISSN: None
EISSN: 19355548
Source Type: Journal
DOI: 10.2337/dc08-s234 Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
